Animab

Ghent, Belgium Founded: 2020 • Age: 6 yrs
Proprietary monoclonal antibody platform is provided for pig intestinal infections.
Request Access

About Animab

Animab is a company based in Ghent (Belgium) founded in 2020.. Animab has raised $13.97 million across 3 funding rounds from investors including VLAIO, Qbic Venture Partners and Seventure Partners. The company has 3 employees as of December 31, 2021. Animab offers products and services including Oral Antibodies and Antibody-Based Approach. Animab operates in a competitive market with competitors including Zoetis, Ceva, Bio-Sourcing, Phage Lab and Proteon Pharmaceuticals, among others.

  • Headquarter Ghent, Belgium
  • Employees 3 as on 31 Dec, 2021
  • Sectors
    Healthcare
    Agriculture
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Animab
Operational Areas
Healthcare → Veterinary & Animal Health
Agriculture → Livestock & Animal Nutrition
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $13.97 M (USD)

    in 3 rounds

  • Latest Funding Round
    $9.95 M (USD), Series A

    Nov 07, 2022

  • Investors
    VLAIO

    & 4 more

  • Employee Count
    3

    as on Dec 31, 2021

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Animab

Animab offers a comprehensive portfolio of products and services, including Oral Antibodies and Antibody-Based Approach. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Antibodies that target intestinal pathogens to improve livestock gut health.

Technology for preventing bacterial colonization in animal feed.

Funding Insights of Animab

Animab has successfully raised a total of $13.97M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $9.95 million completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round Series A — $10.0M
  • First Round

    (27 Oct 2020)

  • Investors Count 5
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2022 Amount Series A - Animab Valuation Qbic Fund
Jun, 2021 Amount Grant - Animab Valuation

investors

Oct, 2020 Amount Seed - Animab Valuation Seventure Partners
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Animab

Animab has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include VLAIO, Qbic Venture Partners and Seventure Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture capital fund investing in technological breakthroughs from universities.
Founded Year Domain Location
Tech & Life Sciences focused stage agnostic VC firm investing in Europe, Asia & the US
Founded Year Domain Location
Investments are made in sustainable agriculture and agribusiness.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Animab

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Animab

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Animab Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Animab

Animab operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zoetis, Ceva, Bio-Sourcing, Phage Lab and Proteon Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Animal medicines, vaccines, and diagnostics are manufactured and supplied.
domain founded_year HQ Location
Animal health therapeutics are developed and supplied globally by Ceva.
domain founded_year HQ Location
Biopharmaceuticals for animals are manufactured and supplied through partnerships.
domain founded_year HQ Location
Bacteriophage treatments for animal infections are developed by the company.
domain founded_year HQ Location
Therapeutics for animal infectious diseases are developed via phage platforms.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Animab

Frequently Asked Questions about Animab

When was Animab founded?

Animab was founded in 2020.

Where is Animab located?

Animab is headquartered in Ghent, Belgium. It is registered at Ghent, East Flanders, Belgium.

Who is the current CEO of Animab?

Alain Wille is the current CEO of Animab.

Is Animab a funded company?

Animab is a funded company, having raised a total of $13.97M across 3 funding rounds to date. The company's 1st funding round was a Seed of $4.02M, raised on Oct 27, 2020.

How many employees does Animab have?

As of Dec 31, 2021, the latest employee count at Animab is 3.

What does Animab do?

Animab was founded in 2020 in Ghent, Belgium, within the veterinary biotechnology sector. A proprietary monoclonal antibody platform is developed for treating intestinal infections in pigs. Oral antibiotics are offered as the flagship product to support piglet health during the post-weaning stage. The antibodies are designed to mimic IgA, enabling passage through colostrum and milk for protection of nursing animals. Operations focus on innovative solutions for animal health challenges.

Who are the top competitors of Animab?

Animab's top competitors include Zoetis, Ceva and Bio-Sourcing.

What products or services does Animab offer?

Animab offers Oral Antibodies and Antibody-Based Approach.

Who are Animab's investors?

Animab has 5 investors. Key investors include VLAIO, Qbic Venture Partners, Seventure Partners, Agri Investment Fund, and V-Bio Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available